Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
10.7M
-
Shares change
-
+147K
-
Total reported value, excl. options
-
$999M
-
Value change
-
+$24.9M
-
Put/Call ratio
-
0.77
-
Number of buys
-
108
-
Number of sells
-
-90
-
Price
-
$93.45
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q1 2018
244 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q1 2018.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.7M shares
of 10.9M outstanding shares and own 97.9% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.5M shares), RENAISSANCE TECHNOLOGIES LLC (993K shares), VANGUARD GROUP INC (826K shares), DIMENSIONAL FUND ADVISORS LP (694K shares), ACADIAN ASSET MANAGEMENT LLC (455K shares), STATE STREET CORP (332K shares), MILLENNIUM MANAGEMENT LLC (290K shares), Marshall Wace North America L.P. (221K shares), AMERICAN CENTURY COMPANIES INC (219K shares), and Man Group plc (197K shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.